Blood Flow Restriction Following Hip Arthroscopy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorRush University Medical Center
About this trial
This study will be a prospective randomized, double-blinded, placebo-controlled trial of patients undergoing primary hip arthroscopy for FAIS and/or labral pathology. All patients who sign the consent form will be enrolled in the study and randomized to one of the two treatment arms. Follow-up will take place at 1-month, 3-months, 6-months, and 1-year.
Eligibility criteria
Qualifiers
Adult patients 18-40
English-speaking
Clinical and radiographic examination (MRI) consistent FAIS and/or labral pathology, and are schedule for primary hip arthroscopy
Written and informed consent for study participation
Disqualifiers
Patients younger than 18 or older than 40 years of age
Non-native English speaker
Revision surgery or prior history of ipsilateral hip or knee surgery
Inability to comply with the proposed follow-up clinic visits
Trial design
Treatments tested in this trial
- Blood Flow Restriction Rehabilitative Therapy
- Sham BFR Rehabilitative Therapy
Treatment groups
56 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov